Navigation Links
Two-Year Results from the Medtronic ENDEAVOR III Trial Confirm,Stent's Positive Clinical Profile

olled in its multiple clinical trials, and the growing volume of positive data and number of patients with long-term follow-up continues to reinforce the stent's favorable safety and efficacy profile. The Endeavor stent is not yet approved for use in the United States.

"With two years of follow-up in nearly 1,300 patients and the volume of positive clinical data we've seen to date, we can continue to have confidence in Endeavor's clinical performance," said Martin Leon, M.D., principal investigator of the ENDEAVOR III clinical trial and Professor of Medicine at Columbia University School of Medicine. "As the Endeavor clinical program has matured, it has provided evidence that consistent and predictable patient outcomes are being sustained through time."

Scott Ward, senior vice president at Medtronic and president of the Vascular business, added: "The Endeavor clinical program continues to generate strong cumulative evidence regarding Endeavor's overall performance. Patients have been 99.7% free from overall stent thrombosis and we've seen no late stent thrombosis in our pooled clinical trials. In addition, Endeavor has demonstrated a sustained reduction in repeat procedures of 61% compared to the Medtronic Driver(R) bare metal stent and Endeavor's death/MI rates have been trending lower than bare metal stents."

Medtronic will present additional long-term data on Endeavor in the coming months. At the EuroPCR meeting in May, Medtronic will provide updated four-year and three-year results from the ENDEAVOR I and ENDEAVOR II trials respectively, as well as new data on the next-generation Endeavor Resolute drug-eluting stent. Results from the ongoing ENDEAVOR IV trial, another large randomized trial (1,548 patients) evaluating Endeavor against the Taxus stent made by Boston Scientific, are expected to be presented in the fall.

The Endeavor stent is made of a cobalt alloy and has a unique modular architecture designed to enhance deliverability
'"/>




Page: 1 2 3

Related medicine technology :

1. Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
2. Two-Year Patient Registry Results Support Safety and Efficacy of Cypher Sirolimus-Eluting Coronary Stent in Real World Uses
3. Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results
4. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
5. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
6. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
7. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
8. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
9. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
Post Your Comments:
(Date:12/3/2009)... , NEW YORK, Dec. 3 Guidepo... today announced the launch of their Sleep Apnea T...onitors and projects trends and market share in th...pnea Tracker captures actual patient usage for 87 ...ed States from 15 different equipment providers go...
(Date:12/3/2009)... , DOYLESTOWN, Pa., Dec. 3 /PRNewswire-F...uigley Corporation, (Nasdaq: QGLY ) www.quigleyc...ted its evaluation of its opportunities to develop...has concluded that it is in its best interests to ...ce, which may include but are not limited to its C...
(Date:12/3/2009)... , FORT WORTH, Texas, Dec. 3 /PRNewsw... Inc. (OTC Bulletin Board: WNDM), a rapidly growin...d today an agreement with the Health Industry Repr...clusive independent sales and marketing representa...; product within the U.S. ,, HIRA will marke...
Breaking Medicine Technology:Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3Cadus Reports Third Quarter 2009 Results 14855 1Cadus Reports Third Quarter 2009 Results 14855 2Cadus Reports Third Quarter 2009 Results 14855 3Cadus Reports Third Quarter 2009 Results 14855 4Cadus Reports Third Quarter 2009 Results 14855 5New Data 3A Cholesterol Management Analysis of Upsher Smiths Slo Niacin 28R 29 Tablets in Combination with Lipitor 28R 29 6301 1New Data 3A Cholesterol Management Analysis of Upsher Smiths Slo Niacin 28R 29 Tablets in Combination with Lipitor 28R 29 6301 2New Data 3A Cholesterol Management Analysis of Upsher Smiths Slo Niacin 28R 29 Tablets in Combination with Lipitor 28R 29 6301 3New Data 3A Cholesterol Management Analysis of Upsher Smiths Slo Niacin 28R 29 Tablets in Combination with Lipitor 28R 29 6301 4Indiana University receives NIH grant to improve health care in East Africa 61442 1Indiana University receives NIH grant to improve health care in East Africa 61442 2Indiana University receives NIH grant to improve health care in East Africa 61442 3
(Date:12/4/2009)..., Dec. 4 Thousands of KPMG LLP emp...nwide today, to participate in a community service...firm,s support for literacy with charitable giving...irm,s long history of volunteerism. Instead of hol... of caring to brighten the holidays for some child...
(Date:12/4/2009)... Dec. 4 The American As...SA) applauds the Senate for ensuring that the Com...isions remain in the final health reform legislati...ing support to elders, people with disabilities an...ass a health care reform bill that will make it af...
(Date:12/4/2009)...ADISON HEIGHTS, Mich., Dec. 4 The ... of BetterInvesting Magazine today announced Al..."Stock to Study" and C.R. Bard, Inc. (NYSE: BC...nvestors, informational and educational use. ,,...pportunities involving its flagship drug Botox and...
(Date:12/4/2009)...N, Dec. 4 In response t...ncy,s (DEA) classification of boldione, desoxymeth...one as "anabolic steroids", under the Controlled S...and CEO of the Natural Products Association (NPA),...nting retailers and manufacturers of dietary suppl...
(Date:12/4/2009)... scientists at Johns Hopkins publishing in the Dec...in made by a gene called "Twist" may be the prover... cells that drive aggressive, metastatic breast ca...on recent work suggesting that it is a relatively ...drives breast cancer, scientists have surmised tha...
Breaking Medicine News(10 mins):Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3
... Providence, RI Using a new tool designed to mea...pical gels designed to prevent the sexual transmis...nd Brown University found that women who have used...safe and effective microbicide has not been identi...
...eaturing Emmy award-winning composer, Yale profess..., March 3 Gary Malkin, Emmy,award-winning compose...,Association of Professional Chaplains Annual Conf...ing is,the life work of our member chaplains," say...
...cyou offers a free online healthcare video and inf...munity, CHARLESTON, S.C., March 3 Today Benefitf...ta site icyou ( http://www.icyou.com ),which merge...althcare videos, as well as communicate with other...
... EVANSTON, Ill. --- Although researchers have lon...es than boys, until now no one has clearly provide...fferences. , For the first time -- and in unambi... harder in girls than in boys during language task...
...tudy says breathing-related problems more likely i...thDay News) -- Obese children are much more likely...ated problems during surgery, says a University of...ctive, non-cardiac surgery, found that obese child...
...OLMDEL, N.J., March 3 Sparta Systems, Inc. (Spart...r in enterprise quality and,compliance management ...leading developer and manufacturer of sterile inje... complexity of the pharmaceutical field, companies...
Other Medicine News:Health News:Researchers develop new tool to predict who will use microbicides 2Health News:Researchers develop new tool to predict who will use microbicides 3Health News:Spiritual Health Experts Speak at Chaplains Conference in Pittsburgh March 8-12 2Health News:Benefitfocus(R) Healthcare Video Portal Merges Community with Credibility 2Health News:Gender differences in language appear biological 2Health News:Gender differences in language appear biological 3Health News:Obese Children Face More Complications During Surgery 2Health News:Bioniche Pharma Chooses TrackWise for its Deviation Control Solution 2
...ew solid-state IRIS Medical IQ 810 infrared diode ... disorders and glaucoma. The Companys top-of-the-l...nological innovation and is designed to perform tr...MIP) procedures in the office and operating room s...
...oconus detected early is best corrected with GP le...be present, GP lenses will help the patient adapt ...istortions of the corneal surface and provide impr...llenge for even the most experienced practitioner....
...ded as "a quantum leap forward in the evolution of... Rose K lens has become the world's most frequentl...keratoconus.,Unlike traditional contact lenses, t...t lens closely mimics the cone like shape of the c...
...odel 614B is our most affordable basic centrifuge.... office. The 614 is also the quietest small lab ce...ill spin up to six (6) test tubes up to 15ml (up t...and is UL/CSA compliant. 30 MINUTE TIMER: Mecha...
Medicine Products: